Review

Serotonin syndrome: Preventing, recognizing, and treating it

Robert Z. Wang, MD, Vishal Vashistha, MD, Sukhdeep Kaur, MBBS and Nathan W. Houchens, MD
Cleveland Clinic Journal of Medicine November 2016, 83 (11) 810-816; DOI: https://doi.org/10.3949/ccjm.83a.15129

ABSTRACT

As the use of serotonergic agents to treat depression has increased, so too has the incidence of serotonin syndrome. We identify the common agents implicated in serotonin syndrome and the clinical tools to diagnose, manage, and prevent serotonergic toxicity.

View Full Text

REFERENCES

  1. ↵
    1. Mojtabai R,
    2. Olfson M
    . National trends in long-term use of antidepressant medications: results from the US National Health and Nutrition Examination Survey. J Clin Psychiatry 2014; 75:169–177.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Watson WA,
    2. Litovitz TL,
    3. Rodgers GC Jr.,
    4. et al
    . 2002 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003;21:353–421.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Lai MW,
    2. Klein-Schwartz W,
    3. Rodgers GC,
    4. et al
    . 2005 Annual Report of the American Association of Poison Control Centers’ national poisoning and exopsure database. Clin Toxicol (Phila) 2006; 44:803–932.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Gillman PK
    . The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13:100–109.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Isbister GK,
    2. Buckley NA
    . The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 2005; 28:205–214.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Woytowish MR,
    2. Maynor LM
    . Clinical relevance of linezolid-associated serotonin toxicity. Ann Pharmacother 2013; 47:388–397.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Lee DO,
    2. Lee CD
    . Serotonin syndrome in a child associated with erythromycin and sertraline. Pharmacotherapy 1999; 19:894–896.
    OpenUrlCrossRefPubMed
    1. Gillman PK
    . Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache 2010; 50:264–272.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Isbister GK,
    2. Buckley NA,
    3. Whyte IM
    . Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust 2007; 187:361–365.
    OpenUrlPubMed
  10. ↵
    1. Mowry JB,
    2. Spyker DA,
    3. Cantilena LR Jr.,
    4. McMillan N,
    5. Ford M
    . 2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila) 2014; 52:1032–1283.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Dunkley EJ,
    2. Isbister GK,
    3. Sibbritt D,
    4. Dawson AH,
    5. Whyte IM
    . The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96:635–642.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Karkare SU,
    2. Bhattacharjee S,
    3. Kamble P,
    4. Aparasu R
    . Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother 2011; 9:109–119.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Weissman J,
    2. Meyers BS,
    3. Ghosh S,
    4. Bruce ML
    . Demographic, clinical, and functional factors associated with antidepressant use in the home healthcare elderly. Am J Geriatr Psychiatry 2011; 19:1042–1045.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Caughey GE,
    2. Roughead EE,
    3. Shakib S,
    4. Vitry AI,
    5. Gilbert AL
    . Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data. Drugs Aging 2011; 28:575–581.
    OpenUrlPubMed
  15. ↵
    1. Iqbal MM,
    2. Basil MJ,
    3. Kaplan J,
    4. Iqbal MT
    . Overview of serotonin syndrome. Ann Clin Psychiatry 2012; 24:310–318.
    OpenUrlPubMed
  16. ↵
    1. Mason PJ,
    2. Morris VA,
    3. Balcezak TJ
    . Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore) 2000; 79:201–209.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Prakash S,
    2. Patel V,
    3. Kakked S,
    4. Patel I,
    5. Yadav R
    . Mild serotonin syndrome: a report of 12 cases. Ann Indian Acad Neurol 2015; 18:226–230.
    OpenUrl
  18. ↵
    1. Davies O,
    2. Batajoo-Shrestha B,
    3. Sosa-Popoteur J,
    4. Olibrice M
    . Full recovery after severe serotonin syndrome, severe rhabdomyolysis, multi-organ failure and disseminated intravascular coagulopathy from MDMA. Heart Lung 2014; 43:117–119.
    OpenUrl
  19. ↵
    1. Pedavally S,
    2. Fugate JE,
    3. Rabinstein AA
    . Serotonin syndrome in the intensive care unit: clinical presentations and precipitating medications. Neurocrit Care 2014; 21:108–113.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Boyer EW,
    2. Shannon M
    . The serotonin syndrome. N Engl J Med 2005; 352:1112–1120.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Velamoor VR,
    2. Norman RM,
    3. Caroff SN,
    4. Mann SC,
    5. Sullivan KA,
    6. Antelo RE
    . Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 1994; 182:168–173.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Isbister GK,
    2. Hackett LP,
    3. Dawson AH,
    4. Whyte IM,
    5. Smith AJ
    . Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity. Br J Clin Pharmacol 2003; 56:441–450.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Graudins A,
    2. Stearman A,
    3. Chan B
    . Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16:615–619.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Lappin RI,
    2. Auchincloss EL
    . Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994; 331:1021–1022.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Gillman PK
    . Successful treatment of serotonin syndrome with chlorpromazine. Med J Aust 1996; 165:345–346.
    OpenUrlPubMed
  26. ↵
    1. Buckley NA,
    2. Dawson AH,
    3. Isbister GK
    . Serotonin syndrome. BMJ 2014; 348:g1626.
    OpenUrlFREE Full Text
  27. ↵
    1. Nisijima K,
    2. Shioda K,
    3. Yoshino T,
    4. Takano K,
    5. Kato S
    . Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int 2003; 43:155–164.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Nisijima K,
    2. Yoshino T,
    3. Yui K,
    4. Katoh S
    . Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 2001; 890:23–31.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Micca JL,
    2. Ruff D,
    3. Ahl J,
    4. Wohlreich MM
    . Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials. BMC Musculoskelet Disord 2013; 14:137.
    OpenUrlCrossRefPubMed
    1. Smith EM,
    2. Pang H,
    3. Cirrincione C,
    4. et al
    5. Alliance for Clinical Trials in Oncology
    . Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013; 309:1359–1367.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Lunn MP,
    2. Hughes RA,
    3. Wiffen PJ
    . Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 2014; 1:CD007115.
    OpenUrlPubMed
  32. ↵
    1. Caughey GE,
    2. Roughead EE,
    3. Shakib S,
    4. McDermott RA,
    5. Vitry AI,
    6. Gilbert AL
    . Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age Ageing 2010; 39:488–494.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Gury C,
    2. Cousin F
    . Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability. Encephale 1999; 25:470–476. French.
    OpenUrlPubMed

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Back to top

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects